summit tirzepatide Effects of on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity How the weight loss drug

The mean change in HbA1c was greater in the tirzepatide treatment groups compared with the placebo group

Drugs like Ozempic and Wegovy have a very long half-life (the time it takes for the body to eliminate half of the drug) [12]

Circulation 141 , 6779 (2020)

However, during clinical trials for diabetes, researchers noticed something remarkable: patients were losing significant amounts of weight as a side effect. This observation led Novo Nordisk to develop Wegovy, which gained FDA approval for chronic weight management in 2021

What the study found By the end of the treatment period, nearly two-thirds (62.9%) of participants taking semaglutide showed resolution of steatohepatitis (inflammation caused by fat buildup) without worsening of liver fibrosis